Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer

Clinical trial NCT00546364 · TERMINATED

Trial details

NCT number: NCT00546364
Sponsor: R-Pharm
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2008-02-01
Primary completion: 2010-03-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.